• Citer

Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH.

par Desmedt, Christine ;Sperinde, Jeff;Piette, Fanny;Huang, Weidong;Jin, Xueguang;Tan, Yuping;Durbecq, Virginie ;Larsimont, Denis ;Giuliani, Rosa;Chappey, Colombe;Buyse, Marc;Winslow, John;Piccart-Gebhart, Martine ;Sotiriou, Christos ;Petropoulos, Christos;Bates, Jessica
Référence Diagnostic molecular pathology, 18, 1, page (22-29)
Publication Publié, 2009-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH.
Auteur:	Desmedt, Christine; Sperinde, Jeff; Piette, Fanny; Huang, Weidong; Jin, Xueguang; Tan, Yuping; Durbecq, Virginie; Larsimont, Denis; Giuliani, Rosa; Chappey, Colombe; Buyse, Marc; Winslow, John; Piccart-Gebhart, Martine; Sotiriou, Christos; Petropoulos, Christos; Bates, Jessica
Informations sur la publication:	Diagnostic molecular pathology, 18, 1, page (22-29)
Statut de publication:	Publié, 2009-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antibodies, Monoclonal -- therapeutic use
	Antineoplastic Agents -- therapeutic use
	Breast -- chemistry
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- mortality
	Breast Neoplasms -- pathology
	Breast Neoplasms -- secondary
	Cohort Studies
	Female
	Humans
	In Situ Hybridization, Fluorescence -- methods
	Middle Aged
	Protein Multimerization
	Receptor, erbB-2 -- analysis
	Survival Analysis
	Treatment Outcome
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1052-9551
	info:doi/10.1097/PDM.0b013e31818ebc69
	info:scp/62449280788
	info:pmid/19214112